PMB joins a Comprehensive Cancer Center Zurich flagship project.
PMB is research partner in the OMD-ZH: The CCCZ Oligometastatic Disease Program. Building on the Advance Care Compass developed with support of the Prototype Fund Award, PMB develops, together with its clinical partners, a digital decision aid for prostate cancer patients.